Search PubMed⌕ Search

Biomedical subjects

R Simon

Publications and source records attributed to R Simon.

At least 343 records · Page 19Linked to original sources

[Therapeutic occlusion of an erroneously implanted aortocoronary venous bypass using transluminal balloon embolization].

Today, therapeutic occlusion of blood vessels can be performed not only by surgical ligation, but also by various transluminal embolization techniques. The use of hardly steerable emboli (e.g. metal coils or gel foam) is, however, associated with the risk of embolic displacement into the circulation. The present case describes the embolization of an ACVB-graft erroneously implanted to a cardiac vein, by means of a catheter system with a detachable silicone-rubber balloon (Bard-Parker mini-balloon system).

Angina Pectoris↗

Late denervation in patients with antecedent paralytic poliomyelitis.

The development of new weakness, fatigue, and pain decades after acute paralytic poliomyelitis is a recognized syndrome. We conducted a controlled study of this syndrome by analyzing clinical, electromyographic, and muscle-biopsy features in 18 patients with a history of poliomyelitis--13 reporting 1 to 20 years of new weakness and 5 without new symptoms. The patients with new weakness also reported new muscle atrophy (9 of 13) and fatigue (10 of 13), symptoms not reported by the controls. The age at the time of acute poliomyelitis, severity of poliomyelitis, residual disability, number of years since acute poliomyelitis, and age at the time of study were comparable in the weakening and control groups. Evidence of remote denervation consistent with antecedent poliomyelitis was demonstrated in all patients by electromyography or muscle biopsy or both. In addition, active denervation (as evidenced by spontaneous activity on conventional electromyography, increased jitter on single-fiber electromyography, or atrophic myofibers) was found in 12 patients in the weakening group and in all 5 controls. Immunohistochemical detection of myofibers expressing the neural-cell adhesion molecule corroborated ongoing denervation in both patient groups. When muscle data from both groups were pooled, correlations were observed between the extent of past reinnervation and the degree of ongoing motor-unit instability. We conclude that the extensive reinnervation of denervated muscle that occurs in paralytic poliomyelitis may be followed by late denervation of the previously reinnervated muscle fibers. Electromyographic and muscle-biopsy evidence of ongoing denervation does not distinguish between stable patients with prior paralytic poliomyelitis and those with new weakness.

Adult↗

Supplemental dietary tyrosine in sepsis and acute hemorrhagic shock.

Previous studies showed that dopamine and norepinephrine levels in rat brain are reduced following stress and that rats fed supplemental tyrosine do not exhibit these reductions. We hypothesized that dietary supplementation with tyrosine would enhance resistance to acute hemorrhagic shock and sepsis by increasing substrate (tyrosine) availability for catecholamine synthesis. Rats were fed either a standard rat chow (6.8 g of tyrosine per kilogram of chow), which supports normal growth, fertility, and longevity, or the same chow supplemented with 10 g of tyrosine per kilogram of chow. Seven days later, the rats underwent cecal ligation and perforation while under intraperitoneal pentobarbital anesthesia. There was a significant increase in survival in the tyrosine-supplemented group. Similarly, in another experiment, tyrosine-supplemented rats were able to tolerate acute fulminant hemorrhagic shock better than were nonsupplemented control animals.

Acute Disease↗

Transposable element Ds2 of Zea mays influences polyadenylation and splice site selection.

In the allele adh1-2F11 of Zea mays the 1.3 kb transposable element Ds2 is inserted in the fourth exon of Adh1. Two major RNAs of 3.0 and 1.6 kb are transcribed from this allele. While the 3.0 kb transcript also contains the Ds2 sequences, the 1.6 kb transcript has lost the Ds2 sequences by an alternative splicing process. In this process, a normal 5' splice site is joined to a cryptic 3' splice site located within exon 4. This cryptic 3' splice site is not used in a wild-type Adh1F allele. Other minor transcripts of adh1-2F11 are prematurely terminated and polyadenylated.

DNA Transposable Elements↗

An interactive computer program for the analysis of growth curves.

An interactive FORTRAN program, MUDIFT, is presented. This program was designed to perform a multivariate distribution-free significance test for the comparison of growth curves. Such a test, not assuming functional forms of individual growth, has proved useful when the variety of observed growth curves was too broad to be represented by the family of growth functions and when there were incomplete observations. A numerical example illustrates the use of MUDIFT to analyze serial data pertaining to the measurable solid tumors in 20 mice treated with liposome incorporated muramyltripeptide phosphatidylethanolamine and a control group of 30 mice. The tumor volumes were recorded weekly for 10 weeks following initial entry into the research protocol. The test hypothesis was whether the tumors grew slower in the treated group than in the control group. The test statistic, an asympotically chi 2 statistic, was 7.312 with df = 2, which was significant at alpha = 0.05.

Animals↗

Interactive statistical analysis of survival data.

This paper describes a SAS macro which facilitates the interactive analysis of right-censored survival data. Such data commonly occur in medical studies. The program produces Kaplan-Meier survival curves on a wide variety of graphics devices. The program also performs log-rank and generalized Wilcoxon significance tests among all plotted curves and for each pairwise contrast if desired. Because the program is intelligent and does not prompt the user for information that it can independently obtain, it is quite easy to use.

Computer Graphics↗

Late increase in luminal diameter of aortocoronary venous bypass grafts associated with an increase in the vascular region under supply.

In a previous study, a significant inverse relation was found between the luminal size of aortocoronary venous bypass grafts and the vascular resistance of the coronary region that was perfused by the bypass graft in late stages after bypass surgery. This observation suggested that changes in the graft-dependent vascular area could influence the luminal size of the vein graft, even when they occurred several years after operation. Whereas it is well established today that aortocoronary vein grafts often decrease in luminal diameter after implantation, an increase in the bypass lumen has so far not been reported. Therefore, changes in luminal diameter of 27 vein grafts in 21 patients who underwent at least two postoperative angiographic studies (first study 8 +/- 5 months after surgery, second study 58 +/- 32 months after surgery) were compared with the size of the vascular region supplied by the bypass. The graft diameter was found to be unchanged between the two studies (3.3 +/- 0.6 versus 3.4 +/- 0.7 mm, p = NS) when the dependent vascular area was unchanged. A significant increase in graft diameter from 2.8 +/- 0.8 to 3.9 +/- 0.9 mm (p less than 0.001) was observed in nine patients in whom the area of perfusion had increased between the two studies because of the development of occlusion or obstruction of major coronary branches that were now perfused from the grafted vessel by way of collateral vessels. These data support the contention that the luminal size of aortocoronary vein grafts can adapt to the needs of the dependent myocardial vascular region even late after operation rather than being the result of a nonreversible degenerative process as commonly assumed.

Adult↗

Effect of four non-ionic contrast media on red blood cells in vitro. I. Morphology.

The influence of four non-ionic contrast media on red blood cell morphology was analyzed. The newly synthesized monomeric iopentol and the dimeric iodixanol were compared with the monomeric iopamidol and iohexol in both hypertonic and isotonic solutions at constant hematocrit of 10%. All contrast media solutions induced morphologic changes of the red blood cells and with differences between the different solutions. In isotonic solutions and with increasing concentration of contrast medium, echinocytes were produced in increasing frequency. In isotonic solution and with a high concentration of contrast medium, iopamidol, iopentol and iohexol produced 50% echinocytes and 50% stomatocytes while iodixanol produced 90-100% stomatocytes. In original solution the hypertonic iopamidol, iopentol and iohexol solutions induced desiccocyte deformation, while the nearly isotonic iodixanol still produced stomatocytes. In all the 90% volume ratio solutions (contrast medium/blood) rouleaux formation was inhibited regardless of type of red blood cell.

Contrast Media↗

Effect of four non-ionic contrast media on red blood cells in vitro. II. Aggregation.

The newly synthesized non-ionic monomeric iopentol and dimeric iodixanol were compared with the non-ionic monomers iopamidol and iohexol in both original hypertonic and isotonic solutions at a constant hematocrit of 35%. All contrast media at all volume ratios (contrast medium/blood) decreased red blood cell aggregation with no difference between the various contrast media. The degree of disaggregation of red blood cells increased with increasing concentration of contrast medium in solution. At the lowest volume ratio (2%) red blood cell aggregation was near that of normal blood. At the volume ratio 50% the disaggregatory effects following both isotonic and hypertonic solutions were pronounced. At a high molar concentration both the isotonic iodixanol and the hypertonic solutions of iohexol, iopentol and iopamidol induced an almost total inhibition of red blood cell aggregation. This indicates that the concentration of contrast medium (chemotoxic effect) for non-ionic contrast media is more important for the disaggregatory effect than the osmolality.

Contrast Media↗

Effect of four non-ionic contrast media on red blood cells in vitro. III. Deformability.

The influence of four non-ionic contrast media and one ionic contrast medium was analyzed on red blood cell deformability in vitro. The newly synthesized non-ionic monomeric iopentol and dimeric iodixanol were compared with the currently used non-ionic monomers iopamidol and iohexol and the ionic monomeric diatrizoate at a constant hematocrit of 8%. The effect on red blood cell deformability was analyzed in 50% volume ratio solutions of both original hypertonic and isotonic contrast media solutions. The samples were studied in a red blood cell filtrometer through new Mynipore microsieves using an improved procedure of data processing. Diatrizoate induced significantly more red blood cell rigidification compared with all non-ionic contrast media solutions and normal blood. There was no difference between the investigated non-ionic contrast media, nor between the non-ionic contrast media and normal blood without additive.

Contrast Media↗

How large should a phase II trial of a new drug be?

A number of statistical designs for phase II trials have been published. These designs are critically reviewed. A new design is also introduced. Data are presented on the response rates observed for new chemotherapeutic agents introduced by the National Cancer Institute since 1975. Based upon this material, it is recommended that two-stage designs with a target sample size of 35-50 patients and substantial probability of early termination are usually appropriate. It is also recommended that for active drugs, two to three such trials are necessary to estimate the response rate with reasonable precision. Precise estimation of phase II response rates is not always important, however. For very rare diseases or situations where several dose levels of a biologic are to be evaluated, selection designs may be most appropriate. Such designs are described. Tables are presented to facilitate the design of new agent phase II clinical trials.

Antineoplastic Agents↗